Quarterly ResultMay 8, 2026, 06:09 AM
InnovAge Q3 Net Loss $(29.46)M; Revenue +15.5% to $251.9M
AI Summary
InnovAge Holding Corp. reported a net loss attributable to the company of $(29.46) million for the three months ended March 31, 2026, a significant increase from $(11.38) million in the prior year period. Total revenues for the quarter grew by 15.5% to $251.94 million. For the nine months ended March 31, 2026, the net loss improved to $(10.82) million from $(29.53) million year-over-year, with operating cash flow increasing to $43.43 million. The company also expanded its operations with a new joint venture in Tampa, Florida, and served approximately 8,050 PACE participants.
Key Highlights
- Net loss attributable to InnovAge Holding Corp. for Q3 2026 was $(29.46) million, compared to $(11.38) million in Q3 2025.
- Total revenues for Q3 2026 increased 15.5% to $251.94 million from $218.14 million in Q3 2025.
- Nine-month net loss attributable to InnovAge Holding Corp. improved to $(10.82) million from $(29.53) million.
- Net cash provided by operating activities for the nine months increased to $43.43 million from $23.87 million.
- Cash and cash equivalents rose to $95.54 million as of March 31, 2026, from $64.13 million at June 30, 2025.
- Company served approximately 8,050 PACE participants as of March 31, 2026.
- Entered a joint venture with Tampa General Hospital for InnovAge Florida PACE II, contributing $28.8 million.
- Redeemable noncontrolling interest was $26.1 million as of March 31, 2026.
Price Impact
More from INNV